Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Compromised Lung Volume in Monitoring Usage of Steroid Therapy on Severe COVID-19

NCT04953247 is registered in ClinicalTrials.gov with Guowei Tu as lead sponsor.

NCT NCT04953247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04953247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Compromised Lung Volume in Monitoring Usage of Steroid Therapy on Severe COVID-19
Lead sponsor
Guowei Tu
Phase
Observational
Overall status
Completed
Start date
February 7, 2020
Completion date
June 20, 2021
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pneumonia, quantitative computed tomography